台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    77.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.65%
  • 成交量
    191
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-臺銀-臺中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

臺銀-臺中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20076.00776.3076.30-7195-3.58%
2025/01/160.376.0000.0076.300.31920.16%
2025/01/140.376.0000.0076.300.31940.14%
2024/12/2700.00277.5077.70-2185-1.08%
2024/12/2600.00177.0077.80-1183-0.55%
2024/12/25175.8000.0076.2011740.57%
2024/12/12173.5000.0073.7011590.63%
2024/12/11272.70073.8073.8021581.24%
2024/12/10573.7400.0073.4051563.19%
2024/12/09575.7000.0075.4051493.34%
2024/11/2700.00178.3078.30-1126-0.79%
2024/11/2200.000.178.7582.00-0.1121-0.06%
2024/11/2100.001.276.6679.40-1.2108-1.14%
2024/11/20176.6000.0076.8011010.99%
2024/11/12176.1000.0076.0011070.93%
2024/10/18178.1000.0078.4011430.70%
2024/09/2500.00182.5082.30-1192-0.52%
2024/09/23282.4500.0082.2022010.99%
2024/08/29281.6000.0082.0022950.68%
2024/08/28282.6500.0082.3022960.68%
2024/08/27179.3000.0080.0012870.35%
2024/08/2200.00179.0079.70-1293-0.34%
2024/08/14177.8000.0078.4012950.34%
2024/08/05472.4800.0072.5042991.33%
2024/08/0100.00179.8080.40-1290-0.34%
2024/06/2800.00183.5083.50-1270-0.37%
2024/06/26284.3000.0084.3022660.75%
2024/06/25182.104.282.5783.50-3.2260-1.24%
2024/06/24188.20296.6589.20-1238-0.42%
2024/06/1100.001097.0097.40-10223-4.47%
2024/06/071100.507100.5099.60-6220-2.72%
2024/05/31094.9000.0094.9002250.00%
2024/05/2800.000.494.3095.90-0.4239-0.15%
2024/05/2700.00294.2094.30-2241-0.83%
2024/04/29496.10195.0095.5033190.94%
2024/04/26095.0000.0095.0003180.01%
2024/04/22094.9000.0094.0003310.00%
2024/03/1800.00295.0094.50-2379-0.53%
2024/03/1400.00195.3095.10-1371-0.27%
2024/03/07099.0000.0099.0003620.00%
2024/03/051101.5000.00100.5013550.28%
2024/02/2900.001105.00105.50-1344-0.29%
2024/02/2700.001104.00103.50-1342-0.29%
2024/02/211104.0000.00104.0013480.29%
2024/02/201106.0000.00106.0013400.29%
2024/02/05295.1500.0094.4022820.71%
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-17天前
逸達營收/去年4.2億、年增115% 今年拚歐、美、中新藥藥證UDN聯合新聞網-23天前
逸達進軍歐盟 首批前列腺癌新劑型新藥正式出貨Anue鉅亨-2024/12/18
逸達 相關文章
逸達 相關影音